344


Homo sapiens (NCBI)

Features
Gene ID: 344
  
Biological name :
  
Synonyms : APOC2 / APO-CII|APOC-II / apolipoprotein C2
  
Possible biological names infered from orthology :
  
Species: Homo sapiens (NCBI)
  
Chr. number:
Strand:
Band:
Gene start:
Gene end:
  
Corresponding Affymetrix probe sets: 204561_x_at (Human Genome U133 Plus 2.0 Array)   206738_at (Human Genome U133 Plus 2.0 Array)   231561_s_at (Human Genome U133 Plus 2.0 Array)   231562_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: RefSeq - 32130518
RefSeq - NC_000019.10
RefSeq - NG_008837.1
RefSeq - NP_000474.2
RefSeq - NM_000483.4
  
See co-cited genes in PubMed
Warning: Please see the Ensembl gene model ENSG00000234906 to get all the annotations available for this gene.


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0001523 retinoid metabolic process TAS
 biological_processGO:0010518 positive regulation of phospholipase activity IDA
 biological_processGO:0010898 positive regulation of triglyceride catabolic process IDA
 biological_processGO:0010902 positive regulation of very-low-density lipoprotein particle remodeling IC
 biological_processGO:0010916 negative regulation of very-low-density lipoprotein particle clearance IDA
 biological_processGO:0016042 lipid catabolic process IEA
 biological_processGO:0032375 negative regulation of cholesterol transport IMP
 biological_processGO:0033344 cholesterol efflux IDA
 biological_processGO:0033700 phospholipid efflux IDA
 biological_processGO:0034370 triglyceride-rich lipoprotein particle remodeling TAS
 biological_processGO:0034371 chylomicron remodeling TAS
 biological_processGO:0034372 very-low-density lipoprotein particle remodeling TAS
 biological_processGO:0034375 high-density lipoprotein particle remodeling TAS
 biological_processGO:0034378 chylomicron assembly TAS
 biological_processGO:0034382 chylomicron remnant clearance IDA
 biological_processGO:0034384 high-density lipoprotein particle clearance IMP
 biological_processGO:0042159 lipoprotein catabolic process IBA
 biological_processGO:0042493 response to drug IEA
 biological_processGO:0042632 cholesterol homeostasis IC
 biological_processGO:0042953 lipoprotein transport IEA
 biological_processGO:0043086 negative regulation of catalytic activity IEA
 biological_processGO:0043691 reverse cholesterol transport IC
 biological_processGO:0045723 positive regulation of fatty acid biosynthetic process IDA
 biological_processGO:0045833 negative regulation of lipid metabolic process IDA
 biological_processGO:0048261 negative regulation of receptor-mediated endocytosis IDA
 biological_processGO:0051006 positive regulation of lipoprotein lipase activity IDA
 biological_processGO:0060697 positive regulation of phospholipid catabolic process IDA
 biological_processGO:0070328 triglyceride homeostasis IMP
 cellular_componentGO:0005576 extracellular region TAS
 cellular_componentGO:0005615 extracellular space IDA
 cellular_componentGO:0005769 early endosome TAS
 cellular_componentGO:0034361 very-low-density lipoprotein particle IDA
 cellular_componentGO:0034362 low-density lipoprotein particle IDA
 cellular_componentGO:0034363 intermediate-density lipoprotein particle IDA
 cellular_componentGO:0034366 spherical high-density lipoprotein particle IDA
 cellular_componentGO:0042627 chylomicron IDA
 molecular_functionGO:0008289 lipid binding IDA
 molecular_functionGO:0016004 phospholipase activator activity IDA
 molecular_functionGO:0042803 protein homodimerization activity IMP
 molecular_functionGO:0043274 phospholipase binding IPI
 molecular_functionGO:0055102 lipase inhibitor activity IDA
 molecular_functionGO:0060230 lipoprotein lipase activator activity IDA


Pathways (from Reactome)
Pathway description
No match


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   

© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr